Skip to main content

Table 4 The evaluation of the response to cytoreductive trearments in MDS patients (n = 102)

From: Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome

Response MF-0/1 (n = 90) MF-2/3 (n = 12) P
ORR 48 (53.3%) 2 (16.7%) 0.017
 CR 30 (33.3%) 1 (8.3%)
 PR 11 (12.2%) 1 (8.3%)
 HI 7 (7.8%) 0 (0.0%)
NR 42 (46.7%) 10 (83.3%)
 SD 6 (6.7%) 2 (16.6%)
 PD 36 (40.0%) 8 (66.7%)
  1. ORR overall response rates, CR complete remission (including marrow CR), PR partial remission, HI hematological Improvement, NR no response, SD stable disease, PD progressive disease